Quick Takeaways
- Third Rock Ventures V, L.P. has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $397,571,941.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Third Rock Ventures V, L.P.
- Location
- Boston, MA
- Summary
- The estimated value of insider holdings of Third Rock Ventures V, L.P. is at least $397,571,941 dollars as of 11 May 2026. Third Rock Ventures V, L.P. is the 10%+ Owner of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $289.6M. Third Rock Ventures V, L.P. is the 10%+ Owner of Septerna, Inc. and owns shares of Septerna, Inc. (SEPN) stock worth about $54.8M. Third Rock Ventures V, L.P. is the 10%+ Owner of CARGO Therapeutics, Inc. and owns shares of CARGO Therapeutics, Inc. stock worth about $53.17M.
- Signature
- /s/ Kevin Gillis, Chief Operating Officer of TRV GP V, LLC, general partner of Third Rock Ventures GP V, L.P., general partner of Third Rock Ventures V, L.P.
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Third Rock Ventures V, L.P. and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Rapport Therapeutics, Inc. ($289,603,841).
- Past-year value change for that position: -$28,270,150.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Third Rock Ventures V, L.P.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | 10%+ Owner | $289,603,841 | -$28,270,150 | -8.9% | 07 May 2026 |
| SEPN | Septerna, Inc. | 10%+ Owner | $54,803,075 | 28 Oct 2024 | ||
| CRGX | CARGO Therapeutics, Inc. | 10%+ Owner | $53,165,025 | 14 Nov 2023 |
Insider Transactions Reported by Third Rock Ventures V, L.P.:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.